STOCK TITAN

DaVita Inc. (DVA) Financials

DVA
Trailing 12 months to June 30, 2026
Revenue $14.0B +6.4% YoY
Net Income $1.2B +2.5% YoY
EPS (Diluted) $12.15 +19.7% YoY
Free Cash Flow $1.6B +25.0% YoY
Market Cap $11.3B as of Oct 8, 2026
Price / Sales 0.8x on $14.0B revenue, trailing 12 months to June 30, 2026
Price / Earnings 9.6x on $1.2B net income, trailing 12 months to June 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DVA SEC filings page.

DaVita Inc. (DVA) reported $14.0B in revenue over the twelve months to Jun 30, 2026, up 6.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DVA FY2025

DaVita converts profit into cash, but rising interest costs and aggressive capital returns now sit alongside negative shareholder equity.

The 2025 cash-flow profile outpaced reported earnings: operating cash flow of $1.89B exceeded net income of $1.08B, indicating earnings were accompanied by substantial non-cash expense. After $576M of capital expenditures, free cash flow fell to $1.31B, showing that cash conversion remains positive but the asset base still absorbs a meaningful share.

Operating margin narrowed to 15.0% in FY2025 from 16.3% in FY2024, so recent revenue expansion did not fully reach operating profit. Interest expense reached $540M in FY2025, making financing costs a more important reason net profit margin settled at 7.9%.

Liabilities reached $16.3B against equity of -$651M in FY2025, so leverage is not meaningfully captured by a conventional debt-to-equity cushion. The $1.31B buyback coincided with retained earnings of -$328M, a combination that left less shareholder capital on the balance sheet.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 56 / 100
Financial Health Score 56/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of DaVita Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
81

DaVita Inc. has an operating margin of 15.0%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 81/100, reflecting efficient cost management and pricing power. This is down from 16.3% the prior year.

Growth
54

DaVita Inc.'s revenue grew 6.5% year-over-year to $13.6B, a solid pace of expansion. This earns a growth score of 54/100.

Leverage
18
Liquidity
33

DaVita Inc.'s current ratio of 1.29 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
68

DaVita Inc. converts 9.6% of revenue into free cash flow ($1.3B). This strong cash generation earns a score of 68/100.

Returns
81
Altman Z-Score Distress
1.62

DaVita Inc. scores 1.62, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

DaVita Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.75x

For every $1 of reported earnings, DaVita Inc. generates $1.75 in operating cash flow ($1.9B OCF vs $1.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
3.79x

DaVita Inc. earns $3.79 in operating income for every $1 of interest expense ($2.0B vs $539.9M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.6B
YoY+5.2%
QoQ+4.1%
5Y CAGR+4.0%

DaVita Inc. generated $3.6B in revenue in Q2 2026. This represents an increase of 5.2% from the same quarter a year earlier. Against the prior quarter it is up 4.1%.

EBITDA
$746.8M
YoY+4.8%
QoQ+13.2%
5Y CAGR+2.5%

DaVita Inc.'s EBITDA was $746.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.8% from the same quarter a year earlier. Against the prior quarter it is up 13.2%.

Net Income
$265.4M
YoY+33.1%
QoQ+34.4%
5Y CAGR-2.0%
10Y CAGR+17.4%

DaVita Inc. reported $265.4M in net income in Q2 2026. This represents an increase of 33.1% from the same quarter a year earlier. Against the prior quarter it is up 34.4%.

EPS (Diluted)
$4.02
YoY+55.8%
QoQ+40.1%
5Y CAGR+8.8%
10Y CAGR+31.5%

DaVita Inc. earned $4.02 per diluted share (EPS) in Q2 2026. This represents an increase of 55.8% from the same quarter a year earlier. Against the prior quarter it is up 40.1%.

Cash & Balance Sheet

Free Cash Flow
$320.3M
YoY+57.6%
QoQ+46.4%
5Y CAGR-9.6%
10Y CAGR-0.3%

DaVita Inc. generated $320.3M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 57.6% from the same quarter a year earlier. Against the prior quarter it is up 46.4%.

Cash & Debt
$669.0M
YoY-5.6%
QoQ+3.8%
5Y CAGR-8.5%
10Y CAGR-6.3%

DaVita Inc. held $669.0M in cash against $10.7B in long-term debt as of Q2 2026.

Shares Outstanding
64M
YoY-10.8%
QoQ-0.6%
5Y CAGR-9.4%
10Y CAGR-11.1%

DaVita Inc. had 64M shares outstanding in Q2 2026. This represents a decrease of 10.8% from the same quarter a year earlier. Against the prior quarter it is down 0.6%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Operating Margin
16.3%
YoY+0.4pp
QoQ+2.2pp
5Y change-0.5pp

DaVita Inc.'s operating margin was 16.3% in Q2 2026, reflecting core business profitability. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Net Margin
7.5%
YoY+1.6pp
QoQ+1.7pp
5Y change-2.6pp

DaVita Inc.'s net profit margin was 7.5% in Q2 2026, showing the share of revenue converted to profit. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$181.5M
YoY-36.0%
QoQ-7.6%
5Y CAGR-5.8%

DaVita Inc. spent $181.5M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 36.0% from the same quarter a year earlier. Against the prior quarter it is down 7.6%.

Capital Expenditures
$169.8M
YoY+40.2%
QoQ+66.5%
5Y CAGR+2.6%
10Y CAGR-0.9%

DaVita Inc. invested $169.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 40.2% from the same quarter a year earlier. Against the prior quarter it is up 66.5%.

R&D Spending

Not reported for Q2 2026.

DVA Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DVA quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$3.6B+5.2%$3.4B+6.0%$3.6B+9.9%$3.4B+4.8%$3.4B+6.1%$3.2B+5.0%$3.3B+4.7%$3.3B+4.6%
SG&A Expenses$423.5M+2.6%$421.9M+12.8%$472.4M+14.0%$414.4M+5.3%$412.8M+12.2%$374.1M+3.2%$414.5M+3.2%$393.5M+4.4%
Operating Income$579.0M+7.7%$481.9M+9.8%$561.1M-0.8%$505.8M-5.4%$537.8M+6.2%$438.9M-9.3%$565.4M+45.0%$534.9M+7.9%
EBITDA$746.8M+4.8%$659.7M+7.2%$740.7M+1.2%$683.3M-5.4%$712.5M+4.5%$615.4M-8.3%$732.0M+27.0%$721.9M+5.5%
Interest Expense$150.3M+2.9%$145.1M+7.5%$108.3M+4.6%$150.6M+11.9%$146.1M+49.4%$135.1M+35.8%$103.5M+44.5%$134.6M+37.2%
Income Tax$91.8M-2.0%$66.2M+22.3%$76.7M+19.0%$68.6M-11.7%$93.7M+30.7%$54.1M-17.8%$64.5M+10.2%$77.7M+12.8%
Net Income$265.4M+33.1%$197.5M+21.2%$566.1M-1.3%$150.3M-30.0%$199.3M-10.5%$162.9M-32.0%$573.7M+37.9%$214.7M-13.0%
EPS (Basic)$4.10+56.5%$2.93+42.9%$3.29+4.1%$2.09-18.4%$2.62+2.3%$2.05-24.9%$3.16+89.2%$2.56-5.2%
EPS (Diluted)$4.02+55.8%$2.87+43.5%$3.22+4.9%$2.04-18.4%$2.58+3.2%$2.00-24.5%$3.07+89.5%$2.50-4.6%
Diluted Shares (Avg)66M-14.6%69M-15.3%N/A74M-14.0%77M-13.0%81M-10.2%N/A86M-8.8%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

DVA Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DVA quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$17.7B+1.2%$17.5B+2.2%$17.5B+1.1%$17.6B+0.3%$17.5B+2.7%$17.1B-1.8%$17.3B+2.3%$17.5B+3.4%
Current Assets$4.2B+2.5%$4.1B+11.7%$4.1B+8.3%$4.1B+1.9%$4.1B+17.9%$3.6B-1.3%$3.7B+19.4%$4.0B+28.8%
Cash & Equivalents$669.0M-5.6%$644.2M+46.8%$676.4M-14.9%$706.0M-34.1%$708.4M+70.1%$438.8M+27.1%$794.9M+109.2%$1.1B+138.2%
Short-Term Investments$19.9M-35.8%$22.3M-69.5%$24.3M-52.4%$30.5M+45.4%$31.0M+49.9%$73.2M+589.5%$51.1M+339.8%$21.0M+79.3%
Inventory$151.5M+3.6%$141.6M-5.9%$160.6M+19.4%$139.1M+7.8%$146.3M+15.4%$150.5M+3.2%$134.6M-6.0%$129.0M+17.7%
Accounts Receivable$2.5B+1.1%$2.5B+5.9%$2.4B+12.5%$2.3B+2.9%$2.4B+6.0%$2.3B-10.5%$2.1B+8.1%$2.3B+12.0%
Long-Term Investments$38.4M-0.9%$39.5M+25.5%$41.0M+21.7%$40.1M+18.6%$38.7M+21.8%$31.4M-34.1%$33.7M-29.7%$33.8M-25.3%
Goodwill$7.6B+1.7%$7.6B+2.2%$7.5B+2.3%$7.5B+4.4%$7.5B+3.7%$7.4B+2.6%$7.4B+3.7%$7.2B+2.0%
Total Liabilities$16.6B+4.3%$16.5B+6.4%$16.3B+7.4%$16.2B+6.1%$15.9B+9.2%$15.5B+4.5%$15.2B+7.4%$15.3B+8.4%
Current Liabilities$2.9B-2.7%$2.9B-1.4%$3.1B+5.7%$3.0B+2.5%$2.9B-2.0%$2.9B+12.5%$3.0B+12.5%$2.9B+16.0%
Non-Current Liabilities$13.8B+5.9%$13.6B+8.2%$13.2B+7.9%$13.2B+7.0%$13.0B+12.1%$12.6B+2.8%$12.2B+6.2%$12.3B+6.7%
Long-Term Debt$10.7B+5.8%$10.5B+10.0%$10.2B+10.8%$10.2B+10.0%$10.1B+19.3%$9.6B+6.2%$9.2B+11.0%$9.3B+11.8%
Total Equity-$765.1M-107.0%-$755.5M-182.9%-$651.1M-637.5%-$571.9M-247.9%-$369.6M-158.4%-$267.1M-128.8%$121.1M-88.5%$386.7M-67.8%
Retained Earnings$81.2M-95.7%-$179.2M-110.6%-$328.4M-121.4%$2.0B+60.5%$1.9B+78.8%$1.7B+102.6%$1.5B+156.5%$1.3B+78.3%

DVA Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DVA quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$490.1M+51.1%$320.8M+78.2%$540.7M-1.3%$841.5M+3.8%$324.2M-59.4%$180.0M+233.5%$547.6M+12.9%$810.4M+22.6%
Depreciation & Amortization$167.8M-3.9%$177.8M+0.8%$179.6M+7.8%$177.5M-5.1%$174.7M-0.5%$176.5M-5.7%$166.6M-10.6%$187.0M-0.7%
Stock-Based CompensationN/A$28.2M-5.4%N/AN/AN/A$29.8M+21.3%N/AN/A
Capital Expenditures$169.8M+40.2%$102.0M-28.8%$145.4M-14.8%$166.1M+19.4%$121.1M-2.9%$143.3M+18.4%$170.7M+7.3%$139.0M+1.6%
Free Cash Flow$320.3M+57.6%$218.8M+495.4%$395.3M+4.9%$675.4M+0.6%$203.1M-69.9%$36.8M+114.4%$377.0M+15.6%$671.4M+28.0%
Investing Cash Flow-$194.3M-189.2%-$139.1M+14.2%-$163.1M+34.2%-$262.5M-79.2%-$67.2M+58.5%-$162.1M+24.7%-$248.0M-47.3%-$146.5M-4.8%
Financing Cash Flow-$270.2M-6177.0%-$213.3M+44.2%-$414.5M+26.6%-$582.2M-7308.6%$4.4M+100.8%-$382.5M-219.8%-$565.1M-40.1%-$7.9M+98.0%
Share Buybacks$181.5M-36.0%$196.4M-61.5%$274.5M-24.9%$240.1M-41.2%$283.7M-21.6%$510.2M+103.3%$365.4M+34.2%$407.9M

Not reported in any period shown, so not listed: Dividends Paid.

DVA Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DVA quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Margin16.3%+0.4pp14.1%+0.5pp15.5%-1.7pp14.8%-1.6pp15.9%0.0pp13.6%-2.1pp17.2%+4.8pp16.4%+0.5pp
Net Margin7.5%+1.6pp5.8%+0.7pp15.6%-1.8pp4.4%-2.2pp5.9%-1.1pp5.1%-2.7pp17.4%+4.2pp6.6%-1.3pp
Return on EquityN/AN/AN/AN/AN/AN/A473.7%+434.3pp55.5%+35.0pp
Return on Assets1.5%+0.4pp1.1%+0.2pp3.2%-0.1pp0.9%-0.4pp1.1%-0.2pp0.9%-0.4pp3.3%+0.9pp1.2%-0.2pp
Current Ratio1.47+0.1x1.42+0.2x1.290.0x1.360.0x1.39+0.2x1.25-0.2x1.26+0.1x1.37+0.1x
Debt-to-EquityN/AN/AN/AN/AN/AN/A75.76+67.9x23.95+17.0x
Asset Turnover0.200.0x0.200.0x0.210.0x0.190.0x0.190.0x0.190.0x0.190.0x0.190.0x
FCF Margin9.0%+3.0pp6.4%+5.3pp10.9%-0.5pp19.8%-0.8pp6.0%-15.1pp1.1%+9.5pp11.4%+1.1pp20.6%+3.8pp

Not reported in any period shown, so not listed: Gross Margin.

Note: Shareholder equity is negative (-$651.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
DaVita Inc. DVA FY2025 $13.6B $1.1B 7.9% $11.3B 56/100
The Ensign Group, Inc. ENSG FY2025 $5.1B $344.0M 6.8% $9.9B 58/100
Chemed Corporation CHE FY2025 $2.5B $265K 0.0% $6.6B 64/100
Option Care Health, Inc. OPCH FY2025 $5.6B $207.6M 3.7% $4.6B 56/100
Universal Health Services, Inc. UHS FY2025 $17.4B $1.5B 8.6% $10.3B 54/100

Frequently Asked Questions

What is DaVita Inc.'s annual revenue?

DaVita Inc. (DVA) reported $13.6B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is DaVita Inc.'s revenue growing?

DaVita Inc. (DVA) revenue grew by 6.5% year-over-year, from $12.8B to $13.6B in fiscal year 2025.

Is DaVita Inc. profitable?

Yes, DaVita Inc. (DVA) reported a net income of $1.1B in fiscal year 2025, with a net profit margin of 7.9%.

DaVita Inc. (DVA) reported diluted earnings per share of $9.84 for fiscal year 2025. This represents a -8.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

DaVita Inc. (DVA) had EBITDA of $2.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, DaVita Inc. (DVA) had $676.4M in cash and equivalents against $10.2B in long-term debt.

DaVita Inc. (DVA) had an operating margin of 15.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

DaVita Inc. (DVA) had a net profit margin of 7.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

DaVita Inc. (DVA) generated $1.3B in free cash flow during fiscal year 2025. This represents a -10.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

DaVita Inc. (DVA) generated $1.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

DaVita Inc. (DVA) had $17.5B in total assets as of fiscal year 2025, including both current and long-term assets.

DaVita Inc. (DVA) invested $575.9M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, DaVita Inc. (DVA) spent $1.3B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

DaVita Inc. (DVA) had 67M shares outstanding as of fiscal year 2025.

DaVita Inc. (DVA) had a current ratio of 1.29 as of fiscal year 2025, which is considered adequate.

DaVita Inc. (DVA) had a return on assets of 6.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

DaVita Inc. (DVA) trades at 9.6x earnings, its market capitalization divided by net income of $1.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $11.3B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DaVita Inc. (DVA) trades at 0.8x sales, its market capitalization divided by revenue of $14.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $11.3B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DaVita Inc. (DVA) has negative shareholder equity of -$651.1M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

DaVita Inc. (DVA) has an Altman Z-Score of 1.62, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

DaVita Inc. (DVA) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

DaVita Inc. (DVA) has an earnings quality ratio of 1.75x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

DaVita Inc. (DVA) has an interest coverage ratio of 3.79x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

DaVita Inc. (DVA) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top